Deciphering the gut microbiome in neurodegenerative diseases and metagenomic approaches for characterization of gut microbes

Show simple item record

dc.contributor.author Singh, Nidhi
dc.contributor.author Singh, Veer
dc.contributor.author Rai, Sachchida Nand
dc.contributor.author Mishra, Vishal
dc.contributor.author Vamanu, Emanuel
dc.contributor.author Singh, Mohan P.
dc.date.accessioned 2023-04-17T11:56:48Z
dc.date.available 2023-04-17T11:56:48Z
dc.date.issued 2022-12
dc.identifier.issn 07533322
dc.identifier.uri http://localhost:8080/xmlui/handle/123456789/2054
dc.description This paper is submitted by the author of IIT (BHU), Varanasi, India en_US
dc.description.abstract The central nervous system has essential role in the regulation of the physiological condition of the human body. Gut microbes cause several types of gastrointestinal diseases like ulcer stomach and intestine and irritable bowel syndrome. Microbes present in the human gut can affect brain function by the release of neuroactive metabolites such as neurotransmitters, hormones, and other compounds. Gut microbial-derived metabolites also have an important role in neurological diseases such as Alzheimer's disease, Parkinson's disease, etc. Vital communication between the gut microbes and the central nervous system is known as the microbiota-gut-brain axis. It provides a communication pathway between the gut and brain which is made up of the vagus nerve, immune system components, and neuroendocrine. Disturbance in gut microbiota composition can alter the central nervous system and enteric nervous system functions. Metagenomics has been employed for the identification, and characterization of gut microbes and microbial-derived metabolites. This review is focused on the gut microbes-brain relationship and the role of gut microbes in neurodegenerative diseases. This study is also focused on major metagenomic approaches and their role in gut microbes characterization. en_US
dc.description.sponsorship University Grants Commission en_US
dc.language.iso en_US en_US
dc.publisher Elsevier Masson s.r.l. en_US
dc.relation.ispartofseries Biomedicine and Pharmacotherapy;Volume 156
dc.subject Bioinformatics en_US
dc.subject Gut microbiota en_US
dc.subject Metagenomic en_US
dc.subject Microbiota-gut-brain axis en_US
dc.subject Neurodegenerative disease en_US
dc.subject Neurodegenerative Diseases en_US
dc.subject Central Nervous System en_US
dc.title Deciphering the gut microbiome in neurodegenerative diseases and metagenomic approaches for characterization of gut microbes en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search in IDR


Advanced Search

Browse

My Account